Nanotechnology Based Repositioning of an Anti-Viral Drug for Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Vineela Parvathaneni
Mimansa Goyal
Nishant S. Kulkarni
Snehal K. Shukla
Vivek Gupta
机构：
[1] St. John’s University,Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences
来源：
Pharmaceutical Research | 2020年 / 37卷
关键词：
drug repositioning; nelfinavir; non-small cell lung cancer; 3D spheroid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Individualized therapy in the adjuvant setting for non-small cell lung cancer (NSCLC)
    Celine Mascaux
    Simon Ekman
    Christophe Dooms
    Frances A. Shepherd
    Current Respiratory Care Reports, 2013, 2 (1): : 1 - 9
  • [32] Phase II study of mitonafide in non-small cell lung cancer (NSCLC)
    Casado, A
    Rosell, R
    GarciaGomez, R
    DiazRubio, E
    PerezManga, G
    Font, A
    Benavides, A
    Martin, M
    INVESTIGATIONAL NEW DRUGS, 1996, 14 (04) : 415 - 417
  • [33] Genetic profile of non-small cell lung cancer (NSCLC): A hospital-based survey in Jinhua
    Chen, Xianguo
    Xu, Bo
    Li, Qiang
    Xu, Xiaoyi
    Li, Xianshuai
    You, Xia
    Yu, Zhaonan
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2020, 8 (09):
  • [34] Development of pharmaceutically scalable inhaled anti-cancer nanotherapy - Repurposing amodiaquine for non-small cell lung cancer (NSCLC)
    Parvathaneni, Vineela
    Kulkarni, Nishant S.
    Chauhan, Gautam
    Shukla, Snehal K.
    Elbatanony, Rasha
    Patel, BrijeshKumar
    Kunda, Nitesh K.
    Muth, Aaron
    Gupta, Vivek
    MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2020, 115
  • [35] Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lung
    Robinson, Lary A. l
    Jaing, Crystal J.
    Campbell, Christine Pierce
    Magliocco, Anthony
    Xiong, Yin
    Magliocco, Genevra
    Thissen, James B.
    Antonia, Scott
    BRITISH JOURNAL OF CANCER, 2016, 115 (04) : 497 - 504
  • [36] Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lung
    Lary A Robinson
    Crystal J Jaing
    Christine Pierce Campbell
    Anthony Magliocco
    Yin Xiong
    Genevra Magliocco
    James B Thissen
    Scott Antonia
    British Journal of Cancer, 2016, 115 : 497 - 504
  • [37] Innovation in Non-Small Cell Lung Cancer (NSCLC): Where Are the Clinically Meaningful Outcomes?
    Hess, Lisa M.
    Able, Steven L.
    Carter, Gebra C.
    Treat, Joseph A.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S369 - S369
  • [38] Non-small cell lung cancer (NSCLC): A review of risk factors, diagnosis, and treatment
    Alduais, Yaser
    Zhang, Haijun
    Fan, Fan
    Chen, Jing
    Chen, Baoan
    MEDICINE, 2023, 102 (08) : E32899
  • [39] Waiting times in early-stage non-small cell lung cancer (NSCLC)
    Saint-Jacques, Nathalie
    Rayson, Daniel
    Al-Fayea, Turki
    Virik, Kiran
    Morzycki, Wojciech
    Younis, Tallal
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (08) : 865 - 870
  • [40] Nivolumab in Non-Small Cell Lung Cancer (NSCLC): The Real-Life Data
    Dudnik, Elizabeth
    Moskovitz, Mor
    Daher, Sameh
    Shamai, Sivan
    Hanovich, Ekaterina
    Shechtman, Yelena
    Abu-Amna, Mahmoud
    Zer, Alona
    Wollner, Mira
    Bar, Jair
    Merimsky, Ofer
    Cyjon, Arnold
    Shochat, Tzippy
    Peled, Nir
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S417 - S418
12345